3,427 results match your criteria Journal of Heart Valve Disease[Journal]


Double Valve Failure Due to Perceval Sutureless Aortic Valve Migration.

J Heart Valve Dis 2018 Jan;27(1):124-126

Cardiac Surgery Unit, Heart Center, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Reggio Calabria, Italy.

A 76-year-old woman was admitted to the authors' hospital with pulmonary edema five months after the successful implantation of a Perceval sutureless aortic valve (Sorin Group Srl, Saluggia, Italy). Both echocardiography and computed tomography scanning demonstrated migration of the aortic valve into the left ventricle, causing severe aortic and mitral (secondary) insufficiency. Following heart team discussions, the sutureless valve was replaced with a standard bioprosthesis (Perimount, Magna Ease; Edwards Lifesciences, Irvine, California, USA) with spontaneous restoration of native mitral valve competence. Read More

View Article

Download full-text PDF

Source
January 2018
5 Reads

Use of AngioVac for Removal of Tricuspid Valve Vegetation.

J Heart Valve Dis 2018 Jan;27(1):120-123

University of Kentucky, Lexington, Kentucky, USA. Electronic correspondence:

The use is reported of the AngioVac system to resolve a case of persistent bacteremia in the setting of MRSA tricuspid valve infective endocarditis. The infection was secondary to intravenous drug use in a patient who had failed multiple antibiotic regimens and was deemed a poor surgical candidate. Read More

View Article

Download full-text PDF

Source
January 2018
2 Reads

Management of Late Paravalvular Leak after Transcatheter Valve Placement in Calcified Mitral Annulus.

J Heart Valve Dis 2018 Jan;27(1):117-119

Oregon Health & Science University, Oregon, USA.

Mitral annular calcification presents a unique challenge to the surgical and interventional management of mitral valve pathology. Herein are presented the details of an emerging use of transcatheter valve replacement not only to salvage an open operation but also to minimize the important late complications of valve migration, resulting in paravalvular leak (PVL). The valve was initially stabilized with balloon valvuloplasty to prevent further migration; a vascular plug was then used to close the PVL. Read More

View Article

Download full-text PDF

Source
January 2018
2 Reads

MitraClip® Repair in Cardiogenic Shock Due to Acute Mitral Regurgitation: From Near-Death to Walking.

J Heart Valve Dis 2018 Jan;27(1):114-116

Cardiology Department, Cardiovascular Institute (ICCV), Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

A patient with ischemic myocardiopathy who had undergone resynchronization therapy was admitted to the authors' institution with progressive dyspnea. Echocardiography demonstrated a left ventricular ejection fraction (LVEF) of 25%, with a massive mitral regurgitation (MR) secondary to anterior leaflet prolapse and posterior leaflet restriction. Despite intensive medical treatment, the patient developed cardiogenic shock and required mechanical ventilation, inotropic support and intra-aortic balloon pumping. Read More

View Article

Download full-text PDF

Source
January 2018
4 Reads

Mitral Chordae Rupture as a Possible First-Time Presentation for Graves’ Disease.

J Heart Valve Dis 2018 Jan;27(1):110-113

Imam Abdulrahman bin Faisal University, College of Medicine, Internal Medicine Department, Saudi Arabia. Electronic correspondence:

Graves' disease is a common cause of hyperthyroidism that can lead to multiple cardiovascular complications. Herein is described the case of a 44-year-old male who presented with new-onset atrial fibrillation and mitral regurgitation secondary to flail anterior mitral leaflet with chordae tendineae rupture. This is a rare complication for Graves' disease, and has been reported only twice previously. Read More

View Article

Download full-text PDF

Source
January 2018
20 Reads

Treatment of Simultaneous Thromboembolism of the Right and Left Coronary Arteries with Thrombus Aspiration in a Patient with a Prosthetic Mitral Valve.

J Heart Valve Dis 2018 Jan;27(1):107-109

Department of Cardiology, Şişli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey.

Prosthetic heart valve thrombosis is a rare, difficult-to-treat condition that increases morbidity and mortality by leading to systemic embolism. Clinically, it presents mainly in the form of stroke, though an embolism be observed in many systems. Acute coronary syndrome, which is rarely observed in patients with a prosthetic heart valve, mostly occurs as non-ST segment elevation myocardial infarction (MI). Read More

View Article

Download full-text PDF

Source
January 2018
8 Reads

TAVI as Therapy of Choice for Aortic Valve Disease in Osteogenesis Imperfecta.

J Heart Valve Dis 2018 Jan;27(1):104-106

Department of Cardiology, Pulmonology and Angiology, University Hospital, Düsseldorf, Germany.

Osteogenesis imperfecta (OI) is a syndrome that is often associated with dysfunction of the aortic valve. Because of the resultant fragile vessels and impaired hemostasis, surgical therapy to treat OI is challenging. Previous reports have suggested that transcatheter aortic valve implantation (TAVI) might be a suitable treatment for this condition. Read More

View Article

Download full-text PDF

Source
January 2018
4 Reads

Excellent Durability of the Mosaic Porcine Aortic Bioprosthesis at Extended Follow Up.

J Heart Valve Dis 2018 Jan;27(1):97-103

Section of Cardiac Surgery, Cardiac Thoracic and Vascular Department, University Hospital, Pisa, Italy. Electronic correspondence:

Background: Biological prostheses are widely employed for aortic valve replacement (AVR). The study aim was to evaluate the performance of the Mosaic porcine bioprosthesis in the aortic position over two decades.

Methods: Between November 1995 and December 2016, a total of 254 patients (194 males, 60 females; mean age 74 ± 9 years) underwent AVR with a Mosaic bioprosthesis at the authors' institution. Read More

View Article

Download full-text PDF

Source
January 2018
5 Reads

Early Hemodynamic Performance of the Crown PRT Aortic Prosthesis: A Prospective Study.

J Heart Valve Dis 2018 Jan;27(1):87-96

Wessex Cardiothoracic Centre, Southampton General Hospital, Tremona Road, Southampton, UK.

Background: Currently, only limited data are available on the rate of hemodynamic progression with clinical outcome in patients receiving the latest Crown PRT aortic prosthesis. The study aim was to report clinical and hemodynamic outcomes in 55 consecutive patients for a follow up of up to one year after Crown PRT implantation.

Methods: Between February and September 2015, a total of 55 patients (34 males, 21 females; mean age 77. Read More

View Article

Download full-text PDF

Source
January 2018
10 Reads

Sociodemographic, Clinical and Patient-Reported Outcomes and Readmission After Heart Valve Surgery.

J Heart Valve Dis 2018 Jan;27(1):78-86

National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.

Background: Readmissions after heart valve surgery represent a significant burden for both the patient and the healthcare system. The study aim was to identify independent predictors of readmission within 180 days after surgery in a population of patients undergoing heart valve surgery.

Methods: Demographic and clinical information was obtained from national registers. Read More

View Article

Download full-text PDF

Source
January 2018
2 Reads

Brachial-Ankle Pulse Waves Reflect the Hemodynamics of Valvular Heart Disease.

J Heart Valve Dis 2018 Jan;27(1):71-77

Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Background: Brachial-ankle pulse wave (ba-PW) analysis is an established technique for assessing arterial stiffness and cardiovascular risk. The peripheral arterial pulse wave configuration may be useful for valvular heart disease (VHD) detection because it is closely related to the physical signs of VHD; however, few reports have been made assessing the efficacy of ba-PW analysis for VHD screening.

Methods: Consecutive VHD patients scheduled for valve surgery were enrolled in the study. Read More

View Article

Download full-text PDF

Source
January 2018
6 Reads

Relationship Between Pulmonary Venous Flow and Prosthetic Mitral Valve Thrombosis.

J Heart Valve Dis 2018 Jan;27(1):65-70

Kartal Koşuyolu Heart Training and Research Hospital, Department of Cardiology, İstanbul, Turkey.

Background: Prosthetic valve thrombosis (PVT) may impair pulmonary venous flow (PVF) and left atrial appendage (LAA) functions. An investigation was conducted to determine the association between left superior PVF and LAA functions and mitral PVT.

Methods: This observational case-control study included 100 consecutive patients (87 females, 13 males; mean age 59 years; range 35-71 years) with mechanical mitral PVT, and 50 age- and gender-matched otherwise healthy controls with normally functioning mitral prostheses. Read More

View Article

Download full-text PDF

Source
January 2018
14 Reads

The Influence of Warfarin Adherence on Time in Therapeutic Range Among Patients with Mechanical Heart Valves.

J Heart Valve Dis 2018 Jan;27(1):55-64

Department of Biochemistry, Namik Kemal University Faculty of Medicine, Tekirdag State Hospital, Tekirdag, Turkey.

Background: Despite considerations of its therapeutic range and multiple drug-food interactions, warfarin is the mainstay of oral anticoagulation in patients with mechanical heart valves (MHVs). The quality of anticoagulation demonstrates variations, with 'time in therapeutic range' (TTR) values usually lower than expected. It has been hypothesized that warfarin adherence is among the modifiable causes of suboptimal coagulation. Read More

View Article

Download full-text PDF

Source
January 2018
2 Reads

Mitral Valve Repair with a Semi-Rigid C-Band Annuloplasty Ring in Ischemic Mitral Regurgitation: Still a Viable Surgical Option?

J Heart Valve Dis 2018 Jan;27(1):47-54

Cardiac Surgery Unit, Tor Vergata University Policlinic, Rome, Italy.

Background: Ischemic mitral valve regurgitation (IMR) develops in approximately 10% of patients after myocardial infarction. Surgical management of IMR is controversial, as many series have failed to demonstrate the superiority of mitral valve repair (MVRep) over mitral valve replacement (MVR) in IMR. Moreover, in the setting of MVRep, the choice of ring type is the subject of much debate. Read More

View Article

Download full-text PDF

Source
January 2018
3 Reads
0.733 Impact Factor

New Mitral Valve Annuloplasty Concept: Optimizing Annular Dynamics and Force Distribution.

J Heart Valve Dis 2018 Jan;27(1):38-46

Department. of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark.

Background: Temporal three-dimensional (3D) analysis of the mitral valve biomechanics has prompted a re-evaluation of surgical approaches and repair device designs to accommodate the natural dynamics of the valve. Such new designs strive to obtain lower annulus restraining forces, resulting in more natural leaflet and chordal stresses. A new annuloplasty system was evaluated using 3D motion and out-of-plane force analysis. Read More

View Article

Download full-text PDF

Source
January 2018
3 Reads

In-Vivo Evaluation of Flexible Mitral Annuloplasty Rings: Are They All the Same?

J Heart Valve Dis 2018 Jan;27(1):32-37

Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark.

Background: Currently, several different flexible mitral annuloplasty rings are available, and their efficacy for surgical repair of the mitral valve is, in general, considered equal. However, clinical experience indicates differences in remodeling capacity that have not yet been quantitatively assessed. The study aim was to compare the biomechanical properties of two commonly used flexible mitral annuloplasty rings in an acute pig model. Read More

View Article

Download full-text PDF

Source
January 2018
3 Reads

Evolution of Veterans Affairs Transcatheter Aortic Valve Replacement Program: The First 100 Patients.

J Heart Valve Dis 2018 Jan;27(1):24-31

Division of Cardiothoracic Surgery, Department of Surgery, University of California San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.

Background: Transcatheter aortic valve replacement (TAVR) is a widely established alternative to surgery in intermediate- and high-risk patients. TAVR program development within the Veterans Affairs (VA) system has been previously described. However, national TAVR registries do not capture VA outcomes data, and few data have been reported regarding TAVR outcomes at lower-volume federal institutions. Read More

View Article

Download full-text PDF

Source
January 2018
3 Reads

Immediate and Long-Term Follow Up Results of Balloon Aortic Valvuloplasty in Congenital Bicuspid Aortic Valve Stenosis Among Young Patients.

J Heart Valve Dis 2018 Jan;27(1):17-23

Department of Cardiology, Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER), Pondicherry, India.

Background: The study aim was to investigate the immediate and long-term results of balloon aortic valvuloplasty (BAV) in young patients (aged ≤20 years) with congenital bicuspid aortic valve presenting with severe aortic stenosis.

Methods: The study involved a single tertiary care center-based retrospective data analysis of immediate and long-term outcomes in patients following balloon valvuloplasty between 2000 and 2011. A total of 92 young patients (mean age 12. Read More

View Article

Download full-text PDF

Source
January 2018
5 Reads

Clinical Significance of Greater Implantation Height with SAPIEN 3 Transcatheter Heart Valve.

J Heart Valve Dis 2018 Jan;27(1):9-16

Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, USA. Electronic correspondence:

Background: A lower rate of permanent pacemaker (PPM) has been linked to a target aortic implantation height (AIH) >0.70, following transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 valve. Based on clinical experience, it was hypothesized that a higher AIH (≥0. Read More

View Article

Download full-text PDF

Source
January 2018
2 Reads

Average Aortic Valve Sclerosis Score Index as a Marker for Significant Coronary Artery Disease in Patients with Non-ST-Elevation Myocardial Infarction or Unstable Angina.

J Heart Valve Dis 2018 Jan;27(1):1-8

Student Research Committee, Faculty of Medicine, Cardiovascular Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

Background: Previous studies have reported an association between aortic valve sclerosis (AVS) and coronary atherosclerosis. However, the threshold of sclerosis used to identify high-risk patients has not yet been determined.

Methods: A total of 225 patients admitted with non- ST-elevation myocardial infarction (NSTEMI) or unstable angina was studied. Read More

View Article

Download full-text PDF

Source
January 2018
11 Reads

Sternal-Sparing Aortic Valve Replacement in a Patient with Osteogenesis Imperfecta: A Case Report.

J Heart Valve Dis 2017 11;26(6):744-746

St. John of God Hospital, Subiaco, WA, Australia.

The case described here is the first reported case of successful isolated aortic valve replacement (AVR) via a right anterior thoracotomy (RAT) in a patient with osteogenesis imperfecta (OI). The most common reported complication in patients with OI undergoing AVR or other cardiac surgery is bleeding and sternal complications. By using a RAT approach, it was possible to replace the aortic valve without major bleeding, transfusion, or sternal complications. Read More

View Article

Download full-text PDF

Source
November 2017
8 Reads

The Perceval Sutureless Valve in Aortic Root Reoperation.

J Heart Valve Dis 2017 11;26(6):741-743

Department of Cardiovascular Surgery, Marmara University School of Medicine, Istanbul, Turkey.

The case is reported of a 62-year-old man with severe aortic regurgitation that was related to failed prior valve-sparing ascending aortic aneurysm repair, and who was successfully treated with a Perceval Sutureless valve. Read More

View Article

Download full-text PDF

Source
November 2017
3 Reads

Congenital Left Ventricular-Right Atrial Communication Gerbode-Type Defect.

J Heart Valve Dis 2017 11;26(6):738-740

Department of Medicine, Division of Cardiology, Maimonides Medical Center, Brooklyn, NY, USA.

Adult congenital heart diseases present a unique challenge in assessing right-sided cardiac chambers, where pressures can be mistakenly calculated using standard echocardiographic formulae. A challenging case is presented of a combined inlet ventricular septal defect and ventriculo-atrial Gerbode defect. The diagnosis of such adult congenital heart diseases requires an in-depth understanding of cardiac pathophysiology and hemodynamics. Read More

View Article

Download full-text PDF

Source
November 2017
24 Reads

The Modified Ross Procedure with Prosthetic Graft Wrap Does Not Prevent Autograft Failure.

J Heart Valve Dis 2017 11;26(6):735-737

Duke University Medical Center, Durham, NC, USA, Electronic correspondence:

The modified Ross procedure, which involves replacement of the aortic valve with a pulmonary autograft root supported within a Dacron tube graft, was developed with the goal of preventing late autograft dilatation and associated aortic insufficiency. The case is reported of an adult patient who had a bicuspid aortic valve (BAV), underwent a modified Ross procedure, and developed severe aortic insufficiency within one year and subsequently required reoperation for aortic valve replacement. While advances have been made to increase the success of the Ross procedure via modifications to prevent aortic root dilatation, no modifications have yet been devised to improve the ability of the pulmonary valve to withstand systemic aortic pressures. Read More

View Article

Download full-text PDF

Source
November 2017
17 Reads

Mitral Valve Malignant Primary Tumor as a Surgical Emergency: Case Report.

J Heart Valve Dis 2017 11;26(6):731-734

Instituto Nacional de Cardiologia, Mexico City, Mexico.

Malignant primary tumors of the heart are among the most unusual forms of cancer. Cardiac malignancy accounts for about 20% of all primary cardiac tumors, with most arising from the atria and less frequently the ventricles; very unusual locations include the great vessels and the cardiac valves. A rare case is presented of a young female that arrived at the authors' emergency room in pulmonary edema and circulatory collapse secondary to a true tumor of the mitral leaflets that caused severe mitral valve stenosis. Read More

View Article

Download full-text PDF

Source
November 2017
18 Reads

MitraClip® Implantation Under Cerebral Protection: A Case Report.

J Heart Valve Dis 2017 11;26(6):728-730

University Hospital Essen, West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, Essen, Germany.

MitraClip® implantation is commonly used in patients with severe mitral regurgitation (MR) and who are at high risk for surgical mitral valve repair. The occurrence of stroke or transient ischemic attack is a potential complication in patients undergoing MitraClip implantation, and incidences of up to 2.6% have been reported. Read More

View Article

Download full-text PDF

Source
November 2017
3 Reads

Early Experience with the Latest-Generation Biological Prosthesis, the Trifecta™ GT.

J Heart Valve Dis 2017 11;26(6):721-727

Cardiac Surgery Department, Hospiten Rambla, Santa Cruz de Tenerife, Spain.

Background: The study aim was to assess the hemodynamic results and implantation technique for the latest-generation St. Jude Medical aortic valve bioprosthesis, the Trifecta™ GT, which was first marketed in 2016.

Methods: The first 100 patients (mean age 74. Read More

View Article

Download full-text PDF

Source
November 2017
28 Reads

Red Cell Distribution Width as a Prognostic Marker in Patients Undergoing Valve Surgery.

J Heart Valve Dis 2017 11;26(6):714-720

Institute of Cardiology, Department of Acquired Cardiac Defects, Warsaw, Poland.

Background: Numerous studies have shown that elevated red cell distribution width (RDW) is associated with poor outcomes in patients with cardiovascular diseases such as acute myocardial infarction, stroke, and chronic heart failure. The prognostic utility of RDW in patients with valvular disease undergoing heart valve surgery is unknown.

Methods: A prospective study was conducted on a group of consecutive patients with hemodynamically significant valvular heart disease that underwent elective valvular surgery. Read More

View Article

Download full-text PDF

Source
November 2017
11 Reads

Antiplatelet Therapy for Long-Term Management of Patients with Mechanical Aortic Prostheses.

J Heart Valve Dis 2017 11;26(6):708-713

Division of Cardiovascular Surgery, Mayaguez Medical Center, Mayaguez, Puerto Rico; Ponce Health Science University, Ponce, Puerto Rico.

Background: A mechanical aortic prosthesis (MAP) may cause platelet activation secondary to shear forces, and the release of adenosine diphosphate (ADP). This platelet-mediated event may lead to arterial embolism. Traditionally, warfarin has been used to treat such cases, although this anticoagulant has no inhibitory effects on platelets. Read More

View Article

Download full-text PDF

Source
November 2017
29 Reads

Frequency and Clinical Significance of Right Atrial Embryonic Remnants Involvement in Infective Endocarditis.

J Heart Valve Dis 2017 11;26(6):700-707

Cardiology Department, Misericordia Hospital, Grosseto, Italy.

Background: The involvement of atrial embryonic remnants in infective endocarditis (IE) has seldom been reported. The study aim was to evaluate the prevalence of vegetations on right atrial embryonic remnants (RAER) in patients with a definitive diagnosis of IE.

Methods: Since 1998, all consecutive patients with suspected IE were referred to the authors' institution to undergo transesophageal echocardiography (TEE). Read More

View Article

Download full-text PDF

Source
November 2017
5 Reads

Clinicopathological Spectrum of Mitral Valve Myxoma.

J Heart Valve Dis 2017 11;26(6):693-699

Department of Medicine, University of Miami Miller School of Medicine, Miami, USA.

Cardiac myxomas are the most common primary tumors of the heart. Although these tumors have been reported in all cardiac chambers, myxomas arising from heart valves are extremely rare. Here, the details are described of a patient with mitral valve myxoma, and a review is provided of 99 cases reported in the literature. Read More

View Article

Download full-text PDF

Source
November 2017
9 Reads

Mitral Valve Repair for Mitral Regurgitation with Congenital Anomalies of the Papillary Muscles.

J Heart Valve Dis 2017 11;26(6):688-692

Department of Cardiovascular Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Background: True parachute mitral valve and parachute-like asymmetric mitral valve are associated with congenital anomalies of the papillary muscles, which involves an abnormal anatomy of the papillary muscles and chordae.

Methods: Two patients are described with mitral valve regurgitation and papillary muscle anomalies. Mitral valve repair using artificial chordae reconstruction and ring annuloplasty was attempted in both cases. Read More

View Article

Download full-text PDF

Source
November 2017
4 Reads

Characterization of Effective Orifice Areas of Mitral Prosthetic Heart Valves: An In-Vitro Study.

J Heart Valve Dis 2017 11;26(6):677-687

Quebec Heart and Lung Institute, Laval University, Québec, Canada.

Background: Reference values of hemodynamic parameters for the assessment of prosthetic heart valves are necessary, and ideally need to be provided by entities independent of the valve manufacturers. Thus, the study aim was to provide, in vitro, normal reference values of the effective orifice area (EOA) for different models and sizes of mitral prosthetic valve, and to assess the determinants of EOA and mean transvalvular pressure gradient (mTPG).

Methods: Four models of mechanical prostheses were tested (one mono-leaflet, three bi-leaflet) and four models of bioprostheses (two bovine pericardial, two porcine) on a double-activation pulsed duplicator that was specifically designed and optimized for assessing the hemodynamic performance of mitral prosthetic valves. Read More

View Article

Download full-text PDF

Source
November 2017
61 Reads

Prevalence and Doppler Echocardiographic Characteristics of Normally Functioning Mitral Prostheses with Mean Gradient ≥10 mmHg.

J Heart Valve Dis 2017 11;26(6):667-676

Regions Hospital Heart Center, St. Paul, MN, USA.

Background: The study aim was to determine the prevalence of normally functioning mitral prostheses with mean gradient ≥10 mmHg, and to identify the characteristics and echocardiographic variables that might be useful to distinguish normal function from dysfunction.

Methods: A total of 56 consecutive patients with a prosthetic mitral valve and mean gradient ≥10 mmHg was retrospectively identified. Nineteen patients without subsequent imaging confirming normal prosthesis function or dysfunction were excluded; hence, 37 patients were classified as obstruction, insufficiency, or normal prosthesis (high-gradient; NPHG). Read More

View Article

Download full-text PDF

Source
November 2017
16 Reads

Long-Term Follow Up After Successful Percutaneous Balloon Mitral Valvuloplasty.

J Heart Valve Dis 2017 11;26(6):659-666

Department of Cardiology, Santa Marta Hospital, Lisbon, Portugal.

Background: Percutaneous balloon mitral valvuloplasty (PMV) is the cornerstone of rheumatic mitral stenosis treatment in suitable patients. Previous studies have reported low rates of technical failure and few major complications, with good long-term results after successful PMV. The study aim was to assess the very long-term outcome in patients after PMV performed at a single tertiary center. Read More

View Article

Download full-text PDF

Source
November 2017
9 Reads

Survival Advantage of MitraClip® Over Medical Treatment in Patients with Mitral Regurgitation: A Meta-Analysis.

J Heart Valve Dis 2017 11;26(6):651-658

Department of Cardiology, University Hospital of León, León, Spain.

Background: The MitraClip® system is a percutaneous treatment for mitral regurgitation (MR) that has shown promising results in patients who are inoperable or at high risk for mitral surgery. Data on the efficacy of the system over optimal medical therapy, above all in patients with functional MR, are scarce. The study aim was to assess the effect of MitraClip on the survival of patients with moderate/severe or severe MR compared to medical therapy, using meta-analytical techniques. Read More

View Article

Download full-text PDF

Source
November 2017
8 Reads

Cardioembolic Stroke from an Atrial Myxoma in a Pediatric Patient: A Case Report and Review of the Literature.

J Heart Valve Dis 2017 11;26(6):646-650

King Fahad Specialist Hospital-Dammam, Al Muraikabat, Dammam, Saudi Arabia.

Cardioembolic stroke is an uncommon phenomenon in pediatric patients. Although the heart is the usual source of the condition, cardiac myxomas are still considered to be a rare cause in children. The case is presented of a 13-year-old, right-handed Saudi boy who showed right-sided weakness for 30 h prior to hospital admission that involved the face, arm, and leg, with slurred speech. Read More

View Article

Download full-text PDF

Source
November 2017
5 Reads

Long-Term Results after Modified Bentall Operation in 200 Patients.

J Heart Valve Dis 2017 11;26(6):639-645

First Department of Adult Cardiac Surgery, Onassis Cardiac Surgery Center, Athens, Greece.

Background: Composite graft replacement of the aortic root is the treatment of choice for an array of aortic root pathologies, such as annuloaortic ectasia, Marfan syndrome and acute or chronic aortic dissection type A. In this retrospective study of the authors' aortic surgery database, an exploration was made of factors related to early and long-term morbidity and mortality of patients who underwent this procedure.

Methods: Between 2000 and 2009, a total of 200 consecutive patients (male:female ratio 4:1; mean age 56. Read More

View Article

Download full-text PDF

Source
November 2017
11 Reads

Valve-Sparing Aortic Root Repair Compared to Composite Aortic Root Replacement: A Systematic Review and Meta-Analysis.

J Heart Valve Dis 2017 11;26(6):632-638

Manchester Aortovascular Institute, Manchester Metropolitan University, Manchester, United Kingdom. Electronic correspondence:

Background: Aortic root aneurysms represent a significant risk of morbidity and mortality. Composite root replacement is the preferred practice for repair, although recently valve-sparing replacement has become a popular alternative. The study aim was to identify comparative studies that simultaneously analyzed composite root and valve-sparing root replacement outcomes. Read More

View Article

Download full-text PDF

Source
November 2017
8 Reads

Electrocardiographic Correlates of Myocardial Injury After Transcatheter Aortic Valve Replacement.

J Heart Valve Dis 2017 11;26(6):624-631

Weill Cornell Medical Center-New York Presbyterian Hospital Department of Cardiothoracic Surgery, New York, USA.

Background: Transcatheter aortic valve replacement (TAVR) is associated with several conduction abnormalities and a need for pacemaker placement. The study aim was to describe all electrocardiographic (ECG) changes seen after TAVR, to compare such changes between transapical (TA) and transfemoral (TF) patient cohorts, and to assess their impact on postoperative outcomes.

Methods: Between March 2009 and July 2014, a total of 286 consecutive patients underwent TAVR at the present authors' institution. Read More

View Article

Download full-text PDF

Source
November 2017
6 Reads

Aortic Valve Prolapse and Aortic Regurgitation During Long-Term Follow Up in Children with Ventricular Septal Defect.

J Heart Valve Dis 2017 11;26(6):616-623

Division of Pediatric Cardiology, Department of Pediatrics, Istanbul University Cerrahpaşa Medical Faculty, Istanbul, Turkey.

Background: Aortic valve prolapse (AVP) and aortic regurgitation (AR) can develop in a subset of patients with ventricular septal defect (VSD). The incidence and progression of AVP and AR with VSD at long-term follow up was evaluated.

Methods: The records of 2,275 patients with isolated VSD who had been diagnosed using echocardiography at the present authors' institution between 1988 and 2014 were reviewed. Read More

View Article

Download full-text PDF

Source
November 2017
3 Reads

Endoaneurysmorrhaphy for a Giant Inferobasal Left Ventricular Aneurysm Restoring Mitral Function.

J Heart Valve Dis 2017 09;26(5):613-615

Clinic for Cardiovascular Surgery at the Heart Center Duisburg, Duisburg, Germany.

Over the years, the surgery of ventricular postinfarction aneurysm has evolved from linear resection to endoaneurysmorrhaphy using a patch. Technically, several aims that include the restoration of ventricular shape and function, exclusion of dead space, minimization of the risk of thrombus formation and restoration of valve function are pursued. Herein is reported the case of a 58-year-old male with a giant inferobasal aneurysm involving the mitral valve apparatus who underwent successful endoaneurysmorrhaphy. Read More

View Article

Download full-text PDF

Source
September 2017
5 Reads

Bentall’s Procedure in Pediatric Mixed Connective Tissue Disease Syndrome: Management of Pediatric Aortic Aneurysm - A Brief Review.

J Heart Valve Dis 2017 09;26(5):610-612

MIOT Hospitals, Manapakkam, Chennai, India.

Mixed connective tissue disease (MCTD) syndrome in children may lead to large aortic aneurysms, which in turn pose a difficult surgical problem. Valve-sparing root replacement is not always a viable option as the disease process invariably affects the aortic valve leaflets. Among pediatric patients, the Ross procedure is contraindicated on account of weakness of the pulmonary root, while Bentall surgery is the 'gold standard' treatment of aortic aneurysm, with reproducible and excellent long-term results. Read More

View Article

Download full-text PDF

Source
September 2017
6 Reads

Septic Shock, Meningoencephalitis and Multiple Pulmonary Emboli: Case Report of an Uncommon Clinical Presentation of Ventricular Septal Defect Acute Infective Endocarditis.

J Heart Valve Dis 2017 09;26(5):606-609

Cardiac Surgery Department, Hospital Ramón y Cajal, Madrid, Spain.

The case is reported of a 55 year-old woman, with a previously known congenital septal defect, who was admitted to the emergency department with a diagnosis of meningoencephalitis, septic shock, and rapid clinical deterioration. Echocardiography revealed a vegetation occupying the right-side heart. Endocarditis affectation of the septal defect, aortic and tricuspid valves was noted and blood cultures were positive for Staphylococcus aureus. Read More

View Article

Download full-text PDF

Source
September 2017
13 Reads

Rescue TAVI for Aortic Regurgitation after Left Ventricular Assist Device Implantation Following Preoperative Impella® Support.

J Heart Valve Dis 2017 09;26(5):603-605

Department of Cardiac Surgery, Ludwig Maximilian University, Munich, Germany.

A patient presented with a decompensated cardiomyopathy requiring invasive hemodynamic support with an Impella® heart pump. Extracorporeal life support (ECLS) became necessary during the further course and the patient was bridged to left ventricular assist device (LVAD) implantation. Postoperatively, the patient did not improve as expected due to new aortic regurgitation (AR) that was most likely caused by the previously placed Impella. Read More

View Article

Download full-text PDF

Source
September 2017
11 Reads

Ross Procedure Following a Dislodged Transcatheter Aortic Valve Replacement.

J Heart Valve Dis 2017 09;26(5):600-602

Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic correspondence:

A 36-year-old pregnant woman with a history of rheumatic heart disease and prior aortic valve replacement and mitral valve repair presented to an outside hospital with severe aortic stenosis. The patient had a cardiac arrest upon labor induction and underwent a transcatheter aortic valve replacement (TAVR), which dislodged two days later. Five months later, the patient underwent removal of the dislodged TAVR and a Ross procedure at the authors' institution. Read More

View Article

Download full-text PDF

Source
September 2017
5 Reads

Pulmonary Hypertension as a Possible Cause of Paradoxical Low-Flow, Low-Gradient Aortic Stenosis.

J Heart Valve Dis 2017 09;26(5):597-599

Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.

Paradoxical low-flow, low-gradient aortic stenosis (LFLG AS) is recognized as a subtype of aortic stenosis. A small left ventricular (LV) cavity with marked LV concentric remodeling leads to a reduced stroke volume in this condition. The case is reported of a paradoxical LFLG AS patient who was undergoing treatment for pulmonary hypertension (PH) and interstitial pneumonia associated with scleroderma. Read More

View Article

Download full-text PDF

Source
September 2017
6 Reads

MitraClip Technique Five Years after Alfieri Stitch Mitral Valve Repair.

J Heart Valve Dis 2017 09;26(5):595-596

Heart Institute, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.

The case is described of a successful MitraClip procedure performed on an 88-year-old patient with severe mitral regurgitation (MR), five years after she had undergone mitral valve repair using the Alfieri surgical procedure. It is suggested that the MitraClip procedure is an option in patients with severe MR persisting after the Alfieri procedure. Video 1: Transesophageal echocardiography before the MitraClip procedure. Read More

View Article

Download full-text PDF

Source
September 2017
3 Reads

Cusp Tear of Trifecta™ Aortic Bioprosthesis Resulting in Acute Heart Failure.

J Heart Valve Dis 2017 09;26(5):592-594

Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria. Electronic correspondence:

Herein is presented the case of an 83-year-old male patient in cardiogenic shock with acute aortic regurgitation that occurred six years after aortic valve replacement (AVR) with a 23 mm Trifecta™ valve. Prosthesis endocarditis was initially suspected because of a floating structure attached to the aortic valve that was visible on echocardiography. Emergency redo-AVR surgery was performed, but no signs of endocarditis were found intraoperatively. Read More

View Article

Download full-text PDF

Source
September 2017
4 Reads

Trileaflet Mitral Valve Treated with the MitraClip® System.

J Heart Valve Dis 2017 09;26(5):589-591

Departamento de Cardiología, Complejo Asistencial Universitario de León, León, Spain.

A 79-year-old woman with a history of ischemic dilated cardiomyopathy, severely depressed left ventricular ejection fraction and significant mitral regurgitation (MR) was admitted to the authors´ institution for percutaneous mitral valve repair. Transesophageal echocardiography (TEE) revealed the presence of a posterior mitral cleft at the P2 level, causing a trileaflet mitral valve that contributed significantly to the regurgitant jet. The procedure was performed under general anesthesia and guided by real-time three-dimensional TEE. Read More

View Article

Download full-text PDF

Source
September 2017
32 Reads